Cargando…
Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo
CONTEXT: Curcumin (Cur) has a short duration of action which limits its therapeutic efficacy. Carbonic acid 17-(1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester 4-[7-(4-hydroxy-3-methoxy-phenyl)-3,5-dioxo-hepta-1,6-dienyl]-2...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704087/ https://www.ncbi.nlm.nih.gov/pubmed/36606719 http://dx.doi.org/10.1080/13880209.2022.2136205 |
_version_ | 1784839986010390528 |
---|---|
author | Zhao, Wenmei Zeng, Mingtang Li, Ke Pi, Chao Liu, Zerong Zhan, Chenglin Yuan, Jiyuan Su, Zhilian Wei, Yuxun Wen, Jie Pi, Fengjuan Song, Xinjie Lee, Robert J. Wei, Yumeng Zhao, Ling |
author_facet | Zhao, Wenmei Zeng, Mingtang Li, Ke Pi, Chao Liu, Zerong Zhan, Chenglin Yuan, Jiyuan Su, Zhilian Wei, Yuxun Wen, Jie Pi, Fengjuan Song, Xinjie Lee, Robert J. Wei, Yumeng Zhao, Ling |
author_sort | Zhao, Wenmei |
collection | PubMed |
description | CONTEXT: Curcumin (Cur) has a short duration of action which limits its therapeutic efficacy. Carbonic acid 17-(1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester 4-[7-(4-hydroxy-3-methoxy-phenyl)-3,5-dioxo-hepta-1,6-dienyl]-2-methoxy-phenyl ester (CUD), as a small molecule derivative of Cur with superior stability, has been developed in our laboratory. OBJECTIVE: CUD-loaded solid lipid nanoparticles (CUD-SLN) were prepared to prolong the duration of the drug action of Cur. MATERIALS AND METHODS: CUD-SLN were prepared with Poloxamer 188 (F68) and hydrogenated soybean phospholipids (HSPC) as carriers, and the prescription was optimized. The in vitro release of CUD and CUD-SLN was investigated. CUD-SLN (5 mg/kg) was injected into Sprague Dawley (SD) rats to investigate its pharmacokinetic behaviour. RESULTS: CUD-SLN features high entrapment efficiency (96.8 ± 0.4%), uniform particle size (113.0 ± 0.8 nm), polydispersity index (PDI) (0.177 ± 0.007) and an appropriate drug loading capacity (6.2 ± 0.1%). Optimized CUD-SLN exhibited sustained release of CUD for about 48 h. Moreover, the results of the pharmacokinetic studies showed that, compared to Cur, CUD-SLN had a considerably prolonged half-life of 14.7 h, slowed its metabolism in vivo by 35.6-fold, and had an improved area under the curve (AUC(0–)(t)) of 37.0-fold. CONCLUSIONS: CUD-SLN is a promising preparation for the development of a small molecule derivative of Cur. |
format | Online Article Text |
id | pubmed-9704087 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-97040872022-11-29 Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo Zhao, Wenmei Zeng, Mingtang Li, Ke Pi, Chao Liu, Zerong Zhan, Chenglin Yuan, Jiyuan Su, Zhilian Wei, Yuxun Wen, Jie Pi, Fengjuan Song, Xinjie Lee, Robert J. Wei, Yumeng Zhao, Ling Pharm Biol Research Article CONTEXT: Curcumin (Cur) has a short duration of action which limits its therapeutic efficacy. Carbonic acid 17-(1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester 4-[7-(4-hydroxy-3-methoxy-phenyl)-3,5-dioxo-hepta-1,6-dienyl]-2-methoxy-phenyl ester (CUD), as a small molecule derivative of Cur with superior stability, has been developed in our laboratory. OBJECTIVE: CUD-loaded solid lipid nanoparticles (CUD-SLN) were prepared to prolong the duration of the drug action of Cur. MATERIALS AND METHODS: CUD-SLN were prepared with Poloxamer 188 (F68) and hydrogenated soybean phospholipids (HSPC) as carriers, and the prescription was optimized. The in vitro release of CUD and CUD-SLN was investigated. CUD-SLN (5 mg/kg) was injected into Sprague Dawley (SD) rats to investigate its pharmacokinetic behaviour. RESULTS: CUD-SLN features high entrapment efficiency (96.8 ± 0.4%), uniform particle size (113.0 ± 0.8 nm), polydispersity index (PDI) (0.177 ± 0.007) and an appropriate drug loading capacity (6.2 ± 0.1%). Optimized CUD-SLN exhibited sustained release of CUD for about 48 h. Moreover, the results of the pharmacokinetic studies showed that, compared to Cur, CUD-SLN had a considerably prolonged half-life of 14.7 h, slowed its metabolism in vivo by 35.6-fold, and had an improved area under the curve (AUC(0–)(t)) of 37.0-fold. CONCLUSIONS: CUD-SLN is a promising preparation for the development of a small molecule derivative of Cur. Taylor & Francis 2022-11-23 /pmc/articles/PMC9704087/ /pubmed/36606719 http://dx.doi.org/10.1080/13880209.2022.2136205 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Zhao, Wenmei Zeng, Mingtang Li, Ke Pi, Chao Liu, Zerong Zhan, Chenglin Yuan, Jiyuan Su, Zhilian Wei, Yuxun Wen, Jie Pi, Fengjuan Song, Xinjie Lee, Robert J. Wei, Yumeng Zhao, Ling Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo |
title | Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo |
title_full | Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo |
title_fullStr | Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo |
title_full_unstemmed | Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo |
title_short | Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo |
title_sort | solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704087/ https://www.ncbi.nlm.nih.gov/pubmed/36606719 http://dx.doi.org/10.1080/13880209.2022.2136205 |
work_keys_str_mv | AT zhaowenmei solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo AT zengmingtang solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo AT like solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo AT pichao solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo AT liuzerong solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo AT zhanchenglin solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo AT yuanjiyuan solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo AT suzhilian solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo AT weiyuxun solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo AT wenjie solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo AT pifengjuan solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo AT songxinjie solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo AT leerobertj solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo AT weiyumeng solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo AT zhaoling solidlipidnanoparticleasaneffectivedrugdeliverysystemofanovelcurcuminderivativeformulationreleaseinvitroandpharmacokineticsinvivo |